RS50298B - Direktno kompresibilna matrica za kontrolisano oslobađanje pojedinačnih dnevnih doza klaritromicina - Google Patents

Direktno kompresibilna matrica za kontrolisano oslobađanje pojedinačnih dnevnih doza klaritromicina

Info

Publication number
RS50298B
RS50298B YUP-592/01A YUP59201A RS50298B RS 50298 B RS50298 B RS 50298B YU P59201 A YUP59201 A YU P59201A RS 50298 B RS50298 B RS 50298B
Authority
RS
Serbia
Prior art keywords
clarithromycin
controlled release
compressibile
matrix
directly
Prior art date
Application number
YUP-592/01A
Other languages
English (en)
Inventor
Darja Ferčej Temeljotov
Milojka Mohar
Mateja Salobir
Barbara Rebič
Marko Opresnik
Original Assignee
Lek Pharmaceuticals D.D.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lek Pharmaceuticals D.D., filed Critical Lek Pharmaceuticals D.D.,
Publication of YU59201A publication Critical patent/YU59201A/sh
Publication of RS50298B publication Critical patent/RS50298B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Abstract

Farmaceutska formulacija sa kontrolisanim oslobađanjem za peroralnu pojedinacnu dnevnu primenu, naznačen time, što obuhvata klaritromicin i smešu masne i hidrofilne komponente. Prijava sadrži još 14 zahteva
YUP-592/01A 1999-02-19 2000-02-17 Direktno kompresibilna matrica za kontrolisano oslobađanje pojedinačnih dnevnih doza klaritromicina RS50298B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SI9900039A SI20150A (sl) 1999-02-19 1999-02-19 Direktno stisljivi matriks za nadzorovano sproščanje celodnevne doze klaritromicina

Publications (2)

Publication Number Publication Date
YU59201A YU59201A (sh) 2004-07-15
RS50298B true RS50298B (sr) 2009-09-08

Family

ID=20432410

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-592/01A RS50298B (sr) 1999-02-19 2000-02-17 Direktno kompresibilna matrica za kontrolisano oslobađanje pojedinačnih dnevnih doza klaritromicina

Country Status (21)

Country Link
EP (1) EP1150686B1 (sr)
AT (1) ATE286736T1 (sr)
AU (1) AU776912B2 (sr)
BG (1) BG65324B1 (sr)
CY (1) CY1107454T1 (sr)
CZ (1) CZ302781B6 (sr)
DE (1) DE60017361T2 (sr)
DK (1) DK1150686T3 (sr)
EE (1) EE05422B1 (sr)
ES (1) ES2235834T3 (sr)
HR (1) HRP20010684B1 (sr)
HU (1) HUP0105481A3 (sr)
PL (1) PL196665B1 (sr)
PT (1) PT1150686E (sr)
RS (1) RS50298B (sr)
RU (1) RU2237480C2 (sr)
SI (2) SI20150A (sr)
SK (1) SK287525B6 (sr)
TR (1) TR200102396T2 (sr)
UA (1) UA74778C2 (sr)
WO (1) WO2000048607A1 (sr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200000054A2 (tr) * 2000-01-05 2001-08-21 Sanovel İlaç San. Ve Ti̇c. Anoni̇m Şi̇rketi̇ Klaritromisin içeren sürekli salım sağlayan tablet formülasyonları.
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
IN192748B (sr) * 2000-08-29 2004-05-15 Ranbaxy Lab Ltd
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6673369B2 (en) 2001-08-29 2004-01-06 Ranbaxy Laboratories Limited Controlled release formulation
CA2405918A1 (en) * 2001-10-01 2003-04-01 Ind-Swift Limited Controlled release macrolide pharmaceutical formulations
SE0103369D0 (sv) * 2001-10-09 2001-10-09 Astrazeneca Ab Pharmaceutical formulation
EP1443910A1 (en) 2001-11-02 2004-08-11 Wockhardt Limited Controlled release compositions for macrolide antimicrobial agents
WO2003082241A2 (en) * 2002-04-03 2003-10-09 Ranbaxy Laboratories Limited Clarithromycin formulations having improved bioavailability
US20060083759A1 (en) * 2002-07-17 2006-04-20 Aleksander Resman Stabilization of the profile of release of active substances from a formulation
CA2494233A1 (en) * 2002-07-29 2004-02-05 Alza Corporation Formulations and dosage forms for controlled delivery of topiramate
US20050232995A1 (en) 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
US8062672B2 (en) 2003-08-12 2011-11-22 Shionogi Inc. Antibiotic product, use and formulation thereof
WO2005023221A1 (en) * 2003-09-05 2005-03-17 Ranbaxy Laboratories Limited Clarithromycin formulations having improved biovailability
US7943585B2 (en) * 2003-12-22 2011-05-17 Sandoz, Inc. Extended release antibiotic composition
BRPI0508743A (pt) * 2004-03-24 2008-01-22 Lupin Ltd composição farmacêutica com uma liberação estendida de eritromicina ou um derivado da mesma, método para o uso de uma composição farmacêutica e processo para a preparação de uma composição farmacêutica
EP2283824B1 (en) 2009-07-30 2017-04-19 Special Products Line S.p.A. Compositions and formulations based on swellable matrices for sustained release of poorly soluble drugs such as clarithromycin

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4331803A (en) * 1980-06-04 1982-05-25 Taisho Pharmaceutical Co., Ltd. Novel erythromycin compounds
JPS60163823A (ja) * 1984-02-03 1985-08-26 Taisho Pharmaceut Co Ltd 経口投与製剤
JPS60214796A (ja) * 1984-04-06 1985-10-28 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシン類の製法
JPS63188621A (ja) * 1987-01-30 1988-08-04 Taisho Pharmaceut Co Ltd 矯味経口製剤
US4808411A (en) * 1987-06-05 1989-02-28 Abbott Laboratories Antibiotic-polymer compositions
IL87219A0 (en) * 1987-08-07 1988-12-30 Abbott Lab Erythromycin formulations for oral administration
JP2553882B2 (ja) * 1987-08-08 1996-11-13 富士写真光機株式会社 走査結像光学系
US5599556A (en) * 1991-12-31 1997-02-04 Abbott Laboratories Prolamine coatings for taste masking
ES2199981T3 (es) * 1994-02-16 2004-03-01 Abbott Laboratories Modo de preparacion de formulaciones farmaceuticas de particulas finas.

Also Published As

Publication number Publication date
AU2704900A (en) 2000-09-04
BG105914A (bg) 2002-05-31
SI20150A (sl) 2000-08-31
TR200102396T2 (tr) 2002-01-21
AU776912B2 (en) 2004-09-23
SK287525B6 (sk) 2011-01-04
HRP20010684B1 (en) 2011-01-31
ATE286736T1 (de) 2005-01-15
YU59201A (sh) 2004-07-15
DK1150686T3 (da) 2005-04-04
BG65324B1 (bg) 2008-02-29
EP1150686B1 (en) 2005-01-12
CY1107454T1 (el) 2012-12-19
PL350419A1 (en) 2002-12-16
SK11972001A3 (sk) 2002-02-05
EE05422B1 (et) 2011-06-15
RU2237480C2 (ru) 2004-10-10
UA74778C2 (en) 2006-02-15
ES2235834T3 (es) 2005-07-16
EE200100433A (et) 2002-12-16
CZ302781B6 (cs) 2011-11-02
HUP0105481A3 (en) 2003-04-28
HUP0105481A2 (hu) 2002-05-29
PL196665B1 (pl) 2008-01-31
HRP20010684A2 (en) 2002-10-31
EP1150686A1 (en) 2001-11-07
CZ20012964A3 (cs) 2002-01-16
DE60017361D1 (de) 2005-02-17
PT1150686E (pt) 2005-05-31
DE60017361T2 (de) 2005-12-22
SI1150686T1 (en) 2005-06-30
WO2000048607A1 (en) 2000-08-24

Similar Documents

Publication Publication Date Title
RS50298B (sr) Direktno kompresibilna matrica za kontrolisano oslobađanje pojedinačnih dnevnih doza klaritromicina
NO971206D0 (no) Forlenget-frigjöringsformulering
DK0841903T3 (da) Orale farmaceutiske præparater indeholdende antimikrobielt virksomme aktivstoffer og sustained release pantoprazol
YU49026B (sh) UPOTREBA 17 Гџ -(N-TERC-BUTILKARBAMOIL)-4-AZA-5-ALFA-ANDROST-1-3-ON ZA PROIZVODNJU LEKA ZA TRETIRANJE ANDROGENE ALOPECIJE
BR9808888A (pt) Formas de dosagem e método de melhorar disfunção erétil masculina
ATE202280T1 (de) Filmbildende pharmazeutische zusammensetzungen zur transdermalen verabreichung
GR1002564B (el) Στερεα απο του στοματος χορηγουμενη φαρμακευτικη μορφη δοσιμετρησεως προγραμματισμενου ρυθμου απελευθερωσεως.
BR0015188A (pt) Composições farmacêuticas
BR9917012A (pt) Comprimido matricial, permitindo a liberação prolongada de gliclazida, após administração por via oral
SE9301171D0 (sv) Pharmaceutical composition containing lipophilic drugs
HUP0101237A1 (hu) Elnyújtott kioldódású gyógyszerkészítmények
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
ES2192234T3 (es) Composiciones farmaceuticas parenterales conteniendo sales de amonioalquilo de acidos 2-arilpropionicos.
DE60019334D1 (de) Antivirale arznei
AU9018898A (en) Phosphazole-containing nucleoside analogs, related compounds, pharmaceutical compositions thereof, and their use in in vitro medicinal treatments
DE69923336D1 (de) Oral anzuwendende buprenorphinhaltige arzneimittel
BR0211198A (pt) Composições farmacêuticas e seu uso
WO2002011694A3 (en) COMPOSITIONS AND DOSAGE FORMS FOR APPLICATION IN ORAL CAVITY IN THE TREATMENT OF MYCOSIS
IL154731A0 (en) Ion-strength independent sustained release pharmaceutical formulation
MA26788A1 (fr) COMPOSITIONS PHARMACEUTIQUES DESTINÉES à L'ADMINISTRATION PAR VOIE ORALE DE PHLOROGLUCINOL ET LEUR PRÉPARATION
ATE301469T1 (de) Pharmazeutische diclofenac-verbindung basierend auf vitamin e, papain und hyaluronidase
BR9710629A (pt) Composi-Æo farmac-utica processo para sua prepara-Æo composto para utiliza-Æo como agente terap-utico e utiliza-Æo e utiliza-Æo de um composto
ITMI931822A1 (it) Composizioni farmaceutiche a base di nimesulide, somministrabili per via orale, non gastrolesive e/o a rilascio controllato
CO4180553A1 (es) Composiciones para el tratamiento de la peridontitis adulta
TH21515A (th) การปลดปล่อยซิซาไพรด์นาน